Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics approved the grant of inducement stock options covering 140,860 shares to 27 new non-executive employees on June 18, 2026, with an exercise price of $3.91 per share. The options vest over three years under the company's Amended and Restated 2021 Inducement Plan.